Autoimmune disease risk may differ by menopausal hormone therapy formulation

Progestogen, erstwhile utilized successful hormone therapy, is recognized for its benefits successful protecting the uterus. A caller survey suggests that its summation limits the accrued hazard of composite autoimmune illness associated with estrogen-only therapy. Results of the survey were presented astatine the 2026 Annual Meeting of The Menopause Society successful San Diego, Oct. 20–24, 2026.